Lycopene and resveratrol dietary supplement

Abstract

A dietary supplement is disclosed comprising lycopene and resveratrol in a range of ratio of lycopene:resveratrol from 1:10 to 10:1. Preferably, the ratio is 1:2 to 1:4. Lycopene is preferably of ≧95% purity and resveratrol is of ≧98% purity. Both lycopene and resveratrol may preferably comprise of nano-sized particles in crystal powder to optimize oral intake in the form of capsule or tablet. In small dosage, it should preferably include a minimum of 5 mg of lycopene and 10 mg of resveratrol. Various range of ratios of lycopene:resveratrol are provided for specific therapeutic purposes including 1:4 for symptomatic relief of arthritis, 1:2 for inhibiting melanoma or carcinoma malignancy, and 1:3 for inhibiting hyperlipoidemia. Generally, our dietary supplement composition may be used as an agent for anti-ageing, anti-oxidative, inhibiting cardiovascular diseases, relieving menopause symptoms and remission of post-operative cancer patients.

1 . A dietary supplement composition comprising lycopene and resveratrol in a range of ratio of lycopene : resveratrol from 1:10 to 10:1. 
     
     
         2 . A dietary supplement composition according to  claim 1  wherein the ratio is 1:2 to 1:4. 
     
     
         3 . A dietary supplement composition according to  claim 1  wherein the lycopene is of ≧95% purity. 
     
     
         4 . A dietary supplement composition according to  claim 3  wherein the lycopene comprises nano-sized particles. 
     
     
         5 . A dietary supplement composition according to  claim 4  wherein the lycopene comprises crystal powder. 
     
     
         6 . A dietary supplement composition according to  claim 1  wherein the resveratrol is of ≧98% purity. 
     
     
         7 . A dietary supplement composition according to  claim 6  wherein the resveratrol comprises nano-sized particles. 
     
     
         8 . A dietary supplement composition according to  claim 7  wherein the resveratrol comprises crystal powder. 
     
     
         9 . A dietary supplement composition according to  claim 2  comprising lycopene:resveratrol in the range of 1:4 for symptomatic relief of arthritis. 
     
     
         10 . A dietary supplement composition according to  claim 2  comprising lycopene:resveratrol in the range of 1:2 for inhibiting carcinoma malignancy. 
     
     
         11 . A dietary supplement composition according to  claim 10  for inhibiting melanoma malignancy. 
     
     
         12 . A dietary supplement composition according to  claim 2  comprising lycopene:resveratrol in the range of 1:3 for inhibiting hyperlipoidemia. 
     
     
         13 . A dietary supplement composition according to  claim 9 , wherein the lycopene and resveratrol act synergistically. 
     
     
         14 . A dietary supplement composition according to  claim 1 , formulated for oral intake. 
     
     
         15 . A dietary supplement composition according to  claim 14  formulated in a capsule or tablet. 
     
     
         16 . A dietary supplement composition according to  claim 15  comprising at least 5 mg of lycopene and 10 mg of resveratrol. 
     
     
         17 . A dietary supplement composition according to  claim 15  formulated in a capsule or tablet form comprising a unit weight of a range taken from 190 to 400 mg. 
     
     
         18 . A dietary supplement composition according to  claim 1 , for use as an agent for anti-ageing, anti-oxidative, inhibiting development of cardiovascular diseases, relieving menopause symptoms and remission of post-operative cancer patients.